Young children at high genetic risk for type 1 diabetes who experience stalled gut microbiome development face roughly three times the risk of developing the condition. Researchers analyzing thousands of longitudinal stool samples from the TEDDY study identified three distinct maturation patterns, publishing their findings in Nature Metabolism.
Children carrying a high genetic predisposition for type 1 diabetes see their risk triple when their early gut bacterial development stalls out rather than diversifying normally. A major international research team led by investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and the Harvard T.H. Chan School of Public Health tracked bacterial shifts across thousands of samples to uncover how microbial maturation trajectories interact with human genetics.
Tracking Twelve Thousand Metagenomes Across the TEDDY International Cohort
The study drew its data from the TEDDY study (The Environmental Determinants of Diabetes in the Young), a prospective international cohort designed to uncover environmental triggers of type 1 diabetes. Researchers examined 12,151 metagenomes extracted from stool samples collected across 887 children during their first six years of life. Participants came from six clinical research centers spanning three U.S. regions—Colorado, Georgia/Florida, and Washington—and three European nations, namely Finland, Germany, and Sweden.
To qualify, infants had to be younger than four months at screening and possess specific high-risk human leukocyte antigen (HLA) genotypes. The analytical dataset ultimately incorporated 877 genotyped individuals, while maturational trajectory analysis focused on a subset of 594 children after excluding genetic outliers and participants with fewer than four metagenomic samples. Blood samples were gathered every three months until age four and biannually thereafter to detect insulin, glutamic acid decarboxylase (GAD), and insulinoma antigen-2 autoantibodies.
Three Distinct Patterns of Early Childhood Gut Development
Through detailed trajectory analysis of the microbiome data, researchers classified early microbial progression into three distinct maturation patterns.
- Early Matured: Gut bacteria diversified quickly within the first 400 days of life and remained stable thereafter, shifting sooner from milk-adapted species like Bifidobacterium toward fiber-degrading microbes that signal readiness for solid food.
- Late Matured: Bacterial development started slowly but eventually accelerated, converging over time toward the early-matured trajectory.
- Early Plateaued: Microbial development started slowly and never caught up, maintaining low diversity and limited divergence from baseline throughout the first 800 days.
Children in the Early Plateaued
group possessed gut microbiomes that remained skewed toward digesting milk sugars long after solid foods had been introduced into their diets. More critically, children with the Early Plateaued pattern faced a threefold higher risk of developing type 1 diabetes or the preceding immune attack compared to those following the other trajectories.
How Host Genetics and Microbial Maturation Intersect
The research team found that underlying host genetics modulate how certain microbiome trajectories translate into disease risk. While the late-matured pattern’s association with diabetes fluctuated depending on individual genetic backgrounds—particularly in pathways governing microbial defense and antiviral immune regulation—the stalled pattern operated independently of heredity.
“The early-plateaued pattern, by contrast, carried higher risk regardless of genetic background.”
Danyue Dong, postdoctoral research fellow at Mass General Brigham
Lead author Danyue Dong noted that combining microbial data with host genetics provides a significantly clearer prognostic picture. Co-corresponding author Dr. Daniel Wang of Mass General Brigham emphasized the potential clinical utility of tracking these shifts early in life.
“Understanding the role of microbiome development in diabetes progression could lead to early prediction and prevention strategies, giving us more options to delay or even prevent the clinical manifestation of this disease.”
Dr. Daniel Wang, co-corresponding author from Mass General Brigham
Current Screening Options and Clinical Limitations
Despite the strong statistical associations found in the study, investigators stressed that the findings represent an observation rather than a direct causative mechanism or an immediate diagnostic test. Because the TEDDY cohort consisted entirely of children with elevated genetic risk, the trajectories may not mirror the general population. Furthermore, detecting the plateau pattern required repeated, longitudinal stool sampling over years, meaning commercial single-sample consumer microbiome tests cannot currently identify these risks.
Families concerned about type 1 diabetes do not need to wait for microbiome interventions to utilize existing tools. Blood tests for islet autoantibodies can detect the early, symptom-free stages of the disease years before clinical onset. Pediatricians and research initiatives such as TrialNet offer screening for relatives of individuals diagnosed with the condition, helping families manage early stages and avoid dangerous complications like diabetic ketoacidosis.
По теме
